Related Experiment Video
Updated: Feb 8, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role
Shao-Ming Shen1, Yan Ji2, Cheng Zhang3
1Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai, 200025, China. smshen01@sibs.ac.cn.
Abstract:
Dysregulation of pre-mRNA alternative splicing (AS) is closely associated with cancers. However, the relationships between the AS and classic oncogenes/tumor suppressors are largely unknown. Here we show that the deletion of tumor suppressor PTEN alters pre-mRNA splicing in a phosphatase-independent manner, and identify 262 PTEN-regulated AS events in 293T cells by RNA sequencing, which are associated with significant worse outcome of cancer patients. Based on these findings, we report that nuclear PTEN interacts with the splicing machinery, spliceosome, to regulate its assembly and pre-mRNA splicing. We also identify a new exon 2b in GOLGA2 transcript and the exon exclusion contributes to PTEN knockdown-induced tumorigenesis by promoting dramatic Golgi extension and secretion, and PTEN depletion significantly sensitizes cancer cells to secretion inhibitors brefeldin A and golgicide A. Our results suggest that Golgi secretion inhibitors alone or in combination with PI3K/Akt kinase inhibitors may be therapeutically useful for PTEN-deficient cancers.
Insights
Tumor suppressor PTEN deletion alters pre-mRNA splicing, impacting cancer patient outcomes. PTEN interacts with the spliceosome, and its depletion sensitizes cancer cells to secretion inhibitors, offering new therapeutic strategies for PTEN-deficient cancers.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- Dysregulation of pre-mRNA alternative splicing (AS) is linked to cancer development.
- The interplay between AS and tumor suppressors like PTEN is not well understood.
Purpose of the Study:
- To investigate the role of PTEN in regulating alternative splicing.
- To identify PTEN-regulated AS events and their association with cancer patient prognosis.
- To explore the therapeutic potential of targeting pathways affected by PTEN loss.
Main Methods:
- RNA sequencing to identify PTEN-regulated AS events in 293T cells.
- Analysis of PTEN-spliceosome interactions.
- Investigating the functional impact of a novel GOLGA2 exon on tumorigenesis.
- Assessing sensitivity to secretion inhibitors in PTEN-depleted cancer cells.
Main Results:
- PTEN deletion alters pre-mRNA splicing independently of its phosphatase activity.
- 262 PTEN-regulated AS events were identified, correlating with worse cancer patient outcomes.
- Nuclear PTEN interacts with the spliceosome, influencing its assembly and splicing.
- A novel GOLGA2 exon (2b) exclusion promotes tumorigenesis via Golgi extension and secretion.
- PTEN depletion sensitizes cancer cells to secretion inhibitors (brefeldin A, golgicide A).
Conclusions:
- PTEN plays a crucial role in regulating alternative splicing through spliceosome interaction.
- PTEN-regulated AS events serve as potential biomarkers for cancer prognosis.
- Targeting Golgi secretion pathways, potentially combined with PI3K/Akt inhibitors, may be effective for PTEN-deficient cancers.
Related Concept Videos
Nuclear Export of mRNA
Pre-mRNA Processing: RNA Splicing
Golgi Apparatus
Golgi Apparatus
The Golgi apparatus is a eukaryotic organelle that has a distinctive ribbon-like appearance. It is a primary sorting and dispatch station for cargo arriving from the ER. Newly arriving vesicles enter the cis face of the Golgi, closest to the ER, and are...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...

